Drug Shortage Report for BLEOMYCIN FOR INJECTION USP

Last updated on 2019-10-10 History
Report ID 92543
Drug Identification Number 02131692
Brand name BLEOMYCIN FOR INJECTION USP
Common or Proper name BLEOMYCIN FOR INJECTION USP
Company Name PFIZER CANADA ULC
Active Ingredient(s) BLEOMYCIN
Strength(s) 15UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRA-ARTERIAL INTRACAVITARY INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1 x 15iu vial
ATC code L01DC
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-09-30
Estimated end date 2019-11-29
Actual end date
Shortage status Actual shortage
Updated date 2019-10-10
Company comments Inventory is on preventative allocation.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-10-10 French Compare
v6 2019-10-10 English Compare
v5 2019-10-01 English Compare
v4 2019-09-30 French Compare
v3 2019-09-30 English Compare
v2 2019-08-28 French Compare
v1 2019-08-28 English Compare